Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
Rianne D.W. Vaes, Lizza E.L. Hendriks, Marc Vooijs, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 930-930
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Immunogenic Cell Death Induction by Ionizing Radiation
Mengqin Zhu, Mengdie Yang, Jiajia Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 181
X‐ray‐Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy
Nanhui Liu, Junjie Zhu, Wenjun Zhu, et al.
Advanced Materials (2023) Vol. 35, Iss. 29
Closed Access | Times Cited: 59
Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
Jiaqi Zhai, Xi Gu, Yang Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Mitochondria‐Targeted Photodynamic and Mild‐Temperature Photothermal Therapy for Realizing Enhanced Immunogenic Cancer Cell Death via Mitochondrial Stress
Shaozhe Wang, Yuxin Guo, Xinping Zhang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 42
Closed Access | Times Cited: 46
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Targeting p53 for Immune Modulation: Exploring Its Functions in Tumor Immunity and Inflammation
Hong Wu, Sarah Leng, David D. Eisenstat, et al.
Cancer Letters (2025), pp. 217614-217614
Closed Access | Times Cited: 2
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
Brecht Decraene, Yihan Yang, Frederik De Smet, et al.
Genes and Immunity (2022) Vol. 23, Iss. 1, pp. 1-11
Open Access | Times Cited: 48
DNA-Based MXFs to Enhance Radiotherapy and Stimulate Robust Antitumor Immune Responses
Yu Yang, Bo Liu, Yuan Liu, et al.
Nano Letters (2022) Vol. 22, Iss. 7, pp. 2826-2834
Closed Access | Times Cited: 48
Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
Ahmed O. Elzoghby, Omar Samir, Hagar E. S. Emam, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2475-2504
Open Access | Times Cited: 11
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
High-dose radiation induces dendritic cells maturation by promoting immunogenic cell death in nasopharyngeal carcinoma
Xianlin Zeng, Xin Jin, Junhong Leng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
An Overview on Immunogenic Cell Death in Cancer Biology and Therapy
Mosar Corrêa Rodrigues, José Athayde Vasconcelos Morais, Rayane Ganassin, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1564-1564
Open Access | Times Cited: 37
The importance of hypoxia in radiotherapy for the immune response, metastatic potential and FLASH-RT
Eui Jung Moon, Kristoffer Petersson, Monica M. Olcina
International Journal of Radiation Biology (2021) Vol. 98, Iss. 3, pp. 439-451
Open Access | Times Cited: 40
Intelligent Self-amplifying Ferroptosis-inducible nanoplatform for enhanced tumor microenvironment reconstruction and combination therapy
Xinru Kong, Zhijing He, Yu Zhang, et al.
Chemical Engineering Journal (2023) Vol. 468, pp. 143729-143729
Closed Access | Times Cited: 15
Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma
Zhizhao Miao, Jisen Li, Sheng Zeng, et al.
ACS Applied Materials & Interfaces (2023) Vol. 16, Iss. 1, pp. 245-260
Closed Access | Times Cited: 15
Integrated Nanorod‐Mediated PD‐L1 Downregulation in Combination with Oxidative‐Stress Immunogene Therapy against Cancer
Shuaiying Wu, Jianzhong Zhang, Jie Pan, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 17
Closed Access | Times Cited: 13
Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis
Jiaxin Liao, Yuqing Zhang, Min-Ying Huang, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106837-106837
Closed Access | Times Cited: 13
Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio
Qiuxia Lu, Weisi Yan, Alan Zhu, et al.
Clinical and Translational Radiation Oncology (2023) Vol. 44, pp. 100691-100691
Open Access | Times Cited: 13
HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress
Jinlin Wen, Xinyan Zhang
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 11
Engineered delivery platform based on bacterial outer membrane vesicles for efficient labeling of 131I and improved radio-immunotherapy
Shen Haidong, Surui Chen, Chonghai Zhang, et al.
Chemical Engineering Journal (2024) Vol. 490, pp. 151837-151837
Closed Access | Times Cited: 4
An Immunogenic Cell Death-Related Gene Signature Predicts the Prognosis and Immune Infiltration of Cervical Cancer
Fangfang Sun, Yuanyuan Sun, Hui Tian
Cancer Informatics (2025) Vol. 24
Open Access
Regulation of immunogenic cell death and potential applications in cancer therapy
Kun Fang, Shuai Yuan, Xue Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Abscopal Effects and Immunomodulation in Skin Cancer Therapy
William J. Nahm, Goranit Sakunchotpanit, Vinod E. Nambudiri
American Journal of Clinical Dermatology (2025)
Closed Access
Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities
Faith Hartley, Martin A. Ebert, Alistair Cook
Clinical & Translational Immunology (2025) Vol. 14, Iss. 4
Open Access
Effects of anlotinib hydrochloride on the expression of immunogenic cell death-related molecules in Cal27 tongue cancer cells
Pengcheng Huang, Jitao Zhu, Lijuan Guo, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top